TITLE

Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis

AUTHOR(S)
Vucic, Steve; Kiernan, Matthew C.
PUB. DATE
August 2007
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Aug2007, Vol. 78 Issue 8, p849
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: While some regard the flail arm syndrome as a variant of amyotrophic lateral sclerosis (ALS), others have argued that it is a distinct clinical entity. Consequently, the present study applied novel central and peripheral nerve excitability techniques to further explore disease pathophysiology in flail arm syndrome. Methods: Cortical and peripheral nerve excitability studies were undertaken in 11 flail arm patients, defined by muscle weakness limited to the proximal aspects of the upper limbs for at least 24 months. Results: Mean age at disease onset (60.3 years) was similar to other ALS phenotypes (58.3 years), with strong male predominance (male:female distribution: flail arm 10:1; ALS 1.5:1; p<0.05) and prolonged disease duration (flail arm 62.5 months; ALS 15.8 months; p<0.05). There was evidence of cortical hyperexcitability in flail arm patients, similar to findings in ALS, with reduction in short interval intracortical inhibition (flail arm 0.8 (0.6)%; ALS 4.1(1 .1 )%; controls 8.5 (1.0)%; p<0.0001) and resting motor threshold (flail arm 53.4 (2.8)%; ALS 56.6 (1.8)%; controls 60.7 (1.5)%; p<0.05), along with an increase in motor evoked potential amplitude (flail arm 49.5 (9.0)%; ALS 44.4 (4.9)%; controls 25.8 (2.8)%; p<0.05). Peripheral nerve excitability studies demonstrated changes consistent with upregulation in persistent Na+ currents and reduction of slow K+ conductances, similar to findings in ALS. Conclusion: This study has demonstrated the presence of cortical hyperexcitability in flail arm syndrome, along with abnormalities in peripheral nerve excitability, findings consistent with previous studies in other ALS phenotypes. By demonstrating the presence of upper motor neuron dysfunction, the present study suggests that the flail arm syndrome is an unusual variant of ALS.
ACCESSION #
26277379

 

Related Articles

  • Corticomotoneuronal function and hyperexcitability in acquired neuromyotonia. Vucic, Steve; Cheah, Benjamin C.; Yiannikas, Con; Vincent, Angela; Kiernan, Matthew C. // Brain: A Journal of Neurology;Sep2010, Vol. 133 Issue 9, p2727 

    Acquired neuromyotonia encompasses a group of inflammatory disorders characterized by symptoms reflecting peripheral nerve hyperexcitability, which may be clinically confused in the early stages with amyotrophic lateral sclerosis. Despite a clear peripheral nerve focus, it remains unclear...

  • Brakiyal Amyotrofik Dipleji: Olgu Sunumu. YÜCEL, Mehmet; ÖZ, Oğuzhan; AKGÜN, Hakan; KORKMAZ, Muammer; ULAŞ, Ümit H.; DEMİRKAYA, Şeref; KÜTÜKÇÜ, Yaşar; ODABAŞI, Zeki // Journal of Neurological Sciences;2011, Vol. 28 Issue 1, p86 

    No abstract available.

  • Chapter 2: The Clinical Features and Prognosis of Amyotrophic Lateral Sclerosis. Mitsumoto, Hiroshi // Amyotrophic Lateral Sclerosis: A Guide for Patients & Families;2009, p21 

    Chapter 2 of the book "Amyotrophic Lateral Sclerosis: A Guide for Patients and Families," Third Edition, is presented. The chapter looks at the symptoms and prognosis of amyotrophic lateral sclerosis (ALS). An overview of the anatomic and physiologic relationship between the motor neuron and the...

  • Administration of Recombinant Heat Shock Protein 70 Delays Peripheral Muscle Denervation in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis. Gifondorwa, David J.; Jimenz-Moreno, Ramon; Hayes, Crystal D.; Rouhani, Hesam; Robinson, Mac B.; Strupe, Jane L.; Caress, James; Milligan, Carol // Neurology Research International;2012, p1 

    A prominent clinical feature of ALS ismuscle weakness due to dysfunction, denervation and degeneration of motoneurons (MNs). While MN degeneration is a late stage event in the ALS mouse model, muscle denervation occurs significantly earlier in the disease. Strategies to prevent this early...

  • Changes in motor cortex excitability during muscle fatigue in amyotrophic lateral sclerosis. Nardone, R.; Buffone, E.; Florio, I.; Tezzon, F. // Journal of Neurology, Neurosurgery & Psychiatry;Mar2005, Vol. 76 Issue 3, p429 

    To further investigate the pathophysiology of amyotrophic lateral sclerosis (ALS), the silent period (SP) evoked by transcranial magnetic stimulation during a fatiguing muscle contraction was evaluated in 15 patients and in 15 healthy subjects. Physiological lengthening of the SP duration was...

  • Fasciculations and cramps: how benign? Report of four cases progressing to ALS. Singh, Varun; Gibson, John; McLean, Brendan; Boggild, Mike; Silver, Nicholas; White, Richard // Journal of Neurology;Apr2011, Vol. 258 Issue 4, p573 

    Clinical diagnosis of amyotrophic lateral sclerosis (ALS) in patients presenting with cramps and fasciculations may not be evident at the first consultation. Sequential reviews, clinical and neurophysiological, form an important part of clinical practice in such cases. Recent attempts to...

  • Fasciculation anxiety syndrome in clinicians. Simon, Neil; Kiernan, Matthew // Journal of Neurology;Jul2013, Vol. 260 Issue 7, p1743 

    The goal of this study is to define the clinical features, pathogenesis and key investigation findings of fasciculation anxiety syndrome in clinicians (FASICS). Twenty consecutive clinicians presenting with fasciculations were prospectively assessed with serial clinical and neurophysiological...

  • Existential Issues in Palliative Care: Interviews of Patients with Amyotrophic Lateral Sclerosis. Bolmsjö, Ingrid // Journal of Palliative Medicine;Dec2001, Vol. 4 Issue 4, p499 

    For the individual as well as for those caring for the patients, the diagnosis of amyotrophic lateral sclerosis (ALS) provides a great emotional challenge. Many factors, including existential distress, contribute to the emotional strain of patients with ALS. This study focuses on patients...

  • IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients. Fiala, Milan; Chattopadhay, Madhuri; La Cava, Antonio; Tse, Eric; Guanghao Liu; Lourenco, Elaine; Eskin, Ascia; Liu, Philip T.; Magpantay, Larry; Tse, Stephen; Mahanian, Michelle; Weitzman, Rachel; Tong, Jason; Nguyen, Caroline; Cho, Tiffany; Koo, Patrick; Sayre, James; Martinez-Maza, Otoniel; Rosenthal, Mark J.; Wiedau-Pazos, Martina // Journal of Neuroinflammation;2010, Vol. 7, p76 

    The contribution of inflammation to neurodegenerative diseases is increasingly recognized, but the role of inflammation in sporadic amyotrophic lateral sclerosis (sALS) is not well understood and no animal model is available. We used enzyme-linked immunosorbent assays (ELISAs) to measure the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics